Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905891 · ClinicalTrials.gov registry record · NA
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01905891 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 7 participants.
The verdict
NCT01905891, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
Interventions
- PROCEDURE Superficial shave biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01905891
The ClinicalTrials.gov registry entry for NCT01905891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Superficial shave biopsy is the first listed.
NCT01905891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01905891 about?
NCT01905891 is a clinical study titled "Nanocytology Test to Evaluate Skin Cancer in High Risk Patients". The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
What is the current status of trial NCT01905891?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01905891?
The interventions under investigation include: Superficial shave biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01905891?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.